Flaveheal MR 35 mg Tablets (Trimetazidine) | Used for the Symptomatic Treatment of Stable Angina as Add-On Therapy

Precaution

Before taking Flaveheal MR 35 mg, inform your healthcare professional about your medical history and all medicines you are currently taking.

Parkinson's Disease and Movement Disorders
Trimetazidine should not be used in people with Parkinson's disease, parkinsonian symptoms, tremor, restless-leg syndrome, or related movement disorders. It can cause or worsen movement-related symptoms such as tremor, stiffness, slow movement, or walking difficulties.

Kidney Problems
Trimetazidine should not be used in severe renal impairment. Patients with moderate kidney impairment may require a reduced dose because exposure to the medicine can increase.

Older Adults
Extra care may be required in people over 75 years of age because kidney function may be reduced and the medicine may remain in the body longer.

Dizziness and Drowsiness
Trimetazidine may cause dizziness or drowsiness in some people. Take care when driving or operating machinery if these symptoms occur.

Pregnancy and Breastfeeding
If you are pregnant, planning pregnancy, or breastfeeding, discuss the use of trimetazidine with your healthcare professional before taking it.

Heart-Related Treatment
Flaveheal MR is intended for stable angina treatment and should be used together with an appropriate overall cardiovascular treatment plan.

Monitoring Movement Symptoms
If new tremors, stiffness, slow movement, balance problems, or walking difficulties develop during treatment, contact your healthcare professional promptly. Treatment should be reassessed if these symptoms occur.

Usage   

Flaveheal MR 35 mg Tablets should be taken orally according to the instructions provided by a healthcare professional. The 35 mg modified-release formulation is generally taken twice daily with meals, typically in the morning and evening, when prescribed at the standard regimen.

Swallow the modified-release tablet as directed and do not change the dose without medical advice. Patients with moderate kidney impairment or those who are older may require a different dosing schedule.

Flaveheal MR is intended for the ongoing symptomatic management of stable angina and is not a treatment for an acute angina attack. Follow the complete treatment plan provided by your healthcare professional.

Uses

• Stable Angina
  Flaveheal MR 35 mg is used for the symptomatic treatment of stable angina, a condition that can cause chest discomfort when the heart muscle does not receive enough oxygen.
• Add-On Treatment for Angina
  It may be prescribed as an add-on medicine when other anti-anginal treatments do not adequately control symptoms or are not tolerated.
• Management of Angina Symptoms
  Trimetazidine helps heart cells use energy more efficiently when oxygen supply is reduced, which may help reduce symptoms associated with stable angina.
• Support During Reduced Oxygen Supply to the Heart
  The medicine acts on the heart's energy metabolism and may help maintain cellular energy production during periods when oxygen availability is limited.
• Long-Term Symptom Management of Stable Angina
  When prescribed as part of an appropriate treatment plan, it can be used for ongoing management of symptoms associated with stable angina.

Side Effects

Flaveheal MR may cause side effects, although not everyone experiences them.

Common Side Effects

Possible side effects can include:

• Dizziness
• Headache
• Abdominal discomfort
• Indigestion
• Nausea
• Vomiting
• Diarrhea
• Weakness or tiredness

These symptoms may be mild, but persistent or troublesome effects should be discussed with a healthcare professional.

Movement-Related Side Effects

Trimetazidine can rarely cause or worsen movement disorders. Symptoms may include:

• Tremor
• Muscle stiffness
• Slow movements
• Difficulty walking
• Balance problems
• Restless-leg symptoms

If these symptoms develop, medical assessment is important. Regulatory guidance recommends discontinuing trimetazidine when movement disorders occur.

Other Serious Effects

Rare reactions can include changes in blood-cell counts, liver problems, or significant allergic reactions. Seek medical attention for unusual bleeding, severe weakness, yellowing of the skin or eyes, facial swelling, or difficulty breathing.

FAQs

1. What is Flaveheal MR 35 mg Tablet used for?

Flaveheal MR contains trimetazidine and is used as add-on treatment for the symptoms of stable angina when other anti-anginal treatments are insufficient or not tolerated.

2. What is the active ingredient in Flaveheal MR?

The active ingredient is Trimetazidine 35 mg in a modified-release tablet formulation.

3. How does Trimetazidine work?

Trimetazidine helps heart cells produce energy more efficiently during reduced oxygen availability by promoting glucose oxidation rather than fatty-acid oxidation.

4. How is Flaveheal MR 35 mg usually taken?

The 35 mg modified-release formulation is generally taken twice daily with meals when prescribed at the standard regimen. Individual dosing may differ, particularly with kidney impairment or older age.

5. Can Flaveheal MR treat a sudden angina attack?

No. Trimetazidine is used for the symptomatic management of stable angina and is not intended to relieve an acute angina attack.

6. Can people with Parkinson's disease take Trimetazidine?

No. Trimetazidine is contraindicated in Parkinson's disease, parkinsonian symptoms, tremor, restless-leg syndrome, and related movement disorders.

7. Can Flaveheal MR be used with other angina medicines?

Yes, trimetazidine is specifically used as an add-on treatment when existing anti-anginal therapy does not adequately control symptoms or is not tolerated.

8. Can kidney problems affect Trimetazidine treatment?

Yes. Trimetazidine should not be used in severe renal impairment, while patients with moderate renal impairment may require a reduced dose.

9. Can Trimetazidine cause dizziness?

Yes. Dizziness can occur, and some people may also experience drowsiness. Use caution when driving or operating machinery if affected.

Interactions

Flaveheal MR 35 mg Tablets contain Trimetazidine. Before starting treatment, inform your doctor or pharmacist about all medicines you are currently taking, including prescription medicines, over-the-counter products, vitamins, and supplements. This helps assess whether any medicine may affect your treatment or increase the risk of unwanted effects.

Other Anti-Anginal Medicines
Flaveheal MR 35 mg is generally used as an add-on treatment for stable angina rather than as a replacement for other prescribed anti-anginal medicines. Tell your doctor about all medicines being used to manage angina so that your overall treatment can be reviewed appropriately.

Medicines for Parkinson’s Disease or Movement Disorders
Trimetazidine should not be used in people with Parkinson’s disease, Parkinsonian symptoms, tremors, restless-leg syndrome, or other related movement disorders. It may cause or worsen movement-related symptoms such as tremor, stiffness, or difficulty walking.

Medicines in People With Kidney Problems
Trimetazidine is eliminated mainly through the kidneys. Medicines or medical conditions that affect kidney function may therefore be relevant to treatment. People with reduced kidney function may require medical assessment and an appropriate dose adjustment.

Medicines That May Cause Dizziness or Weakness
If you take other medicines that can cause dizziness, weakness, or drowsiness, inform your healthcare professional. Combining medicines with similar effects may make these symptoms more noticeable in some people.

Other Prescription and Non-Prescription Medicines
Always provide a complete list of your medicines before starting Trimetazidine. This includes medicines for heart conditions, blood pressure, diabetes, neurological conditions, and any regularly used supplements.